ArticleBMC cancer2022

PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): a pragmatic phase III randomized controlled trial.

Cynthia Ménard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.